Trophoblast invasion dynamics improve through protein-mediated enhancement of uterine vascular remodelling pathways

Chenghong Xie1, Jingqiong Zhan1, Yufang Xiang1

  • 1The First College of Clinical Medical Science, China Three Gorges University, Gynaecology and Obstetrics, Yichang Central People's Hospital, Yichang, Hubei Province, China.

Background: In early pregnancy, trophoblast invasion and uterine vascular remodelling must be tightly regulated to ensure maternal-foetal circulation. Inhibition of these processes causes preeclampsia, foetal development retardation, and recurrent pregnancy loss. It is unclear whether molecular regulators control trophoblast invasiveness and uterine vascular adaption, despite much investigation. Methods: Here, a Protein-Mediated Vascular Remodelling Enhancement (PM-VRE) technique is proposed to examine trophoblast invasion mediated by particular regulatory proteins by increasing uterine vascular remodelling. Protein expression profiling and pathway interaction analysis comprise PM-VRE. Results: Experiments show protein signalling drives endothelial transformation, artery remodelling, and trophoblast migration, with upregulated angiogenic and matrix pathways enabling vascular adaptation. It achieves higher trophoblast invasion depths (∼195-210 µm), enhanced endothelial responsiveness (up to 95%), increased ECM remodelling activity (∼75-80), greater vascular resistance reduction (∼78%), and improved placental perfusion stability (up to 90). Conclusion: PM-VRE provides an effective framework for identifying molecular regulators of trophoblast invasion and uterine vascular remodeling, offering insights into mechanisms underlying placental development and pregnancy disorders associated with impaired placentation.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...